BiondVax Pharmaceuticals

+$0.02 (+2.13%) Today
-$0.01 (-0.83%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BVXV and other ETFs, options, and stocks.

About BVXV

BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza.

CEO
Amir Reichman
Employees
15
Headquarters
Jerusalem, Jerusalem
Founded
2003

BVXV Key Statistics

Market cap
22.35M
Price-Earnings ratio
—
Dividend yield
—
Average volume
40.67K
High today
$1.22
Low today
$1.14
Open price
$1.14
Volume
19.36K
52 Week high
$4.19
52 Week low
$1.00

BVXV Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 25, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure